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Opioid-related drug overdose deaths continue to rise at an
alarming rate and have reached the level of a national crisis
[1,2]. Timely administration of naloxone (Narcan®) can reverse
the respiratory depression characteristic of opioid overdoses. A
series of state legislative changes have recently occurred enabling
law enforcement to carry and administer naloxone [3,4]. Pennsylvania (PA), a state with one of the highest rates of death due to
opioid overdose, enacted PA Act 139 in 2014, which allows ﬁrst
responders to administer naloxone to people with suspected
overdoses and provides immunity to those responding to and
reporting overdoses [1,2]. The Act also mandated an online training program – approved by the PA Department of Health - for police ofﬁcers in PA [2].
The purpose of our study was to determine the extent and
speciﬁcs of naloxone use by police ofﬁcers 4 years after the implementation of PA Act 139. After obtaining IRB approval, data was collected using an online survey link, which was distributed via email
to members of the statewide Fraternal Order of Police and the Chiefs
of Police Association by an internal member of each organization.
The online survey was intended for law enforcement ofﬁcers that
were currently working or had retired after September 30, 2014,
the date when law enforcement agents became authorized to
administer naloxone. The survey, administered via a commercial
survey service, consisted of 16 questions and was available for approximately 5 months. A follow-up reminder email was sent by
each participating organization approximately 1 month after the
initial survey distribution.
A total of 980 survey responses were analyzed. The majority of
responding ofﬁcers were not retired (89.0%), work mostly in a suburban area (61.8%), in a local or county police department (94.5%),
and have served N20 years (53.5%). In addition, the majority had access to naloxone (90.7%) and were usually ﬁrst on-scene in response to a potential narcotic overdose dispatch (73.1%). Of those
with and without access to naloxone, most were from a suburban
location (58.5% and 38.3%, respectively) and considered their
primary police department to be local/county (91.7% and 93.6%,
respectively).
When looking at naloxone use across the type of primary law
enforcement service, 47.3% of urban law enforcement ofﬁcers,
52.8% of suburban law enforcement ofﬁcers, and 35.5% of rural
law enforcement ofﬁcers reported having personally administered

naloxone. The majority of state police (92.3%) and local/county police (84.9%) reported administering naloxone 1–9 times (Fig. 1).
When comparing the mean number of times naloxone was administered, results did not vary by type of primary police service, p =
.20 (Table 1).
Law enforcement ofﬁcers who had used naloxone reported
positive outcomes after administering the medication. Three quarters (74.6%) of respondents reported utilizing naloxone in a patient in cardiac arrest and 80% of those patients had Return of
Spontaneous Circulation (ROSC). Nearly three quarters of respondents (72.4%) reported never (54.1%) or only once (18.3%) needing to restrain a patient post-naloxone administration (Table 1,
Fig. 2).
Our results are consistent with previous studies that have
shown that training law enforcement to administer naloxone can
lead to more favorable outcomes following an opioid overdose.
Fisher et al. reported that trained ofﬁcers administered naloxone
126 times from April 2014 to September 2015; 82.5% of patients
were successfully resuscitated after police administration of naloxone [5]. Avetian et al. reported similarly positive results [6].
They sent a survey to ﬁrst responders and community-based organizations and reported 261 intranasal administrations of 4 mg
naloxone. Outcomes were reported in 245 of these cases, with
98.8% of them being successful [6]. Davis et al. reported on recent
policy changes in Massachusetts where several communities have
supplied EMTs, ﬁreﬁghters, and paramedics with naloxone [7].
Rando et al. reported a prospective study which demonstrated
that supplying police ﬁrst responders with naloxone decreased
opioid overdose deaths; 78% of those receiving naloxone survived
[8]. As of March 2018, 2300 law enforcement agencies in 42 states
reported a naloxone rescue program involving law enforcement
[9].
The passage of legislation enabling administration of naloxone
by law enforcement in the Commonwealth of Pennsylvania has
been associated with relatively common use and generally positive outcomes. The majority of police ofﬁcers that responded had
access to naloxone and almost half had personally administered
the medication. The results of this study may inform new teaching
initiatives and support increased law enforcement use of this
agent.
Author contributions
All authors provided substantial contributions to conception and
design, acquisition of data, or analysis and interpretation of data. All
authors gave ﬁnal approval of the version of the article to be
published.
Declaration of competing interest
None.

0735-6757/© 2020 Elsevier Inc. All rights reserved.

Downloaded for Anonymous User (n/a) at Lehigh Valley Health Network from ClinicalKey.com by Elsevier on March 07,
2022. For personal use only. No other uses without permission. Copyright ©2022. Elsevier Inc. All rights reserved.

Pennsylvania law enforcement use of Narcan

1945

Fig. 1. Percentage of respondents in state or local/county police departments by number of times administered Narcan (collapsed categories).
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Table 1
Associations between demographic variables and number of times administered Narcan
(n = 475).
1–9
(n = 404)

10–20
(n = 57)

How many total years of service do you currently have?
b1
2 (66.7)
0
1–9
90 (79.0)
21 (18.4)
10–20
143 (85.6)
20 (12.0)
N20
169 (88.5)
16 (8.4)

N20
(n = 14)

0.0540a
1 (33.3)
3 (2.6)
4 (2.4)
6 (3.2)

Is your primary police department considered state or county/local?
State police
12 (92.3)
0
1 (7.7)
Local/County police
392 (84.9)
57 (12.3)
13 (2.8)
Percentages might not add to 100% due to rounding.
a
Fisher's Exact test was used to calculate p-value.
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Fig. 2. Percentage of yes/no responses to each incident-speciﬁc question.
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